Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection

• Status: Unknown status
• Trial end date: 2016-08-01
• Target enrollment: 0
• Participant gender: All

Summary

We are doing this research study to determine if taking vancomycin in addition to a broad-spectrum antibiotic will decrease the chance of developing recurrent Clostridium difficile infection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Spectrum Health Hospitals
• Treatments: Vancomycin

Criteria

Inclusion Criteria:

1. In patients >19 years of age

2. History of C. difficile diarrhea within 16 weeks and treated with Flagyl or Vancomycin during last episode.

3. Patients started on antibiotics during current admission for any other indication at any point of time during hospital course.

Exclusion Criteria:

1. Current diagnosis of CDI

2. First episode of CDI during this admission.

3. Allergy to Vancomycin or other known intolerance

4. Pregnant

h) Patient has received broad-spectrum antibiotics for more than 48 hours for this admission j) Incarceration